Shopping Cart
- Remove All
Your shopping cart is currently empty
KRAS G12D inhibitor 20 (Compound 14) is a selective G12D KRAS inhibitor with antitumor activity.

| Description | KRAS G12D inhibitor 20 (Compound 14) is a selective G12D KRAS inhibitor with antitumor activity. |
| In vitro | KRAS G12D inhibitor 20 (72 h) exhibits antiproliferative activity against human pancreatic cancer cell lines PANC-1 (KRAS G12D) and BxPC3 (KRASwt), with IC 50 values of 5.5 μM and 8.2 μM, respectively, demonstrating low cytotoxicity to normal cells. |
| In vivo | KRAS G12D inhibitor 20 (6 mg/kg, intraperitoneal injection, 6 doses) does not significantly affect the body weight of healthy BALB/c female mice. In a xenograft mouse model using immunodeficient SCID male mice carrying KRASG12D (PANC-1), KRAS G12D inhibitor 20 (6 mg/kg, intraperitoneal injection) reduces tumor volume by 13.1%. |
| Formula | C18H26N6O |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.